Importantly, KLX can ameliorate myocardial infarction-induced cardiac damage by inhibiting the expression of the NLRP3 inflammasome, reducing the release of proinflammatory cytokines IL-1β and IL-18, and suppressing pyroptotic cell death [15]. Here, IL18 is linked to myocardial infarction.